A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
Clinical trial NCT06317311 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06317311
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2026-07-15
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.